Robert Balk to Antibody Formation
This is a "connection" page, showing publications Robert Balk has written about Antibody Formation.
Connection Strength
0.007
-
Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group. JAMA. 1994 Jun 15; 271(23):1836-43.
Score: 0.007